| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6487693 | Current Opinion in Biotechnology | 2015 | 6 Pages |
Abstract
- Synthetic biology is quickly moving from proof of concept to industrial application.
- Pharmaceuticals are a promising target for advanced genetic engineering.
- Genome sequence data indicate vast underexploited biosynthetic capacity.
- Synthetic biology can create libraries of novel chemicals enriched for bioactivity.
- Synthetic biology expands the range of available chassis organisms for industry.
Related Topics
Physical Sciences and Engineering
Chemical Engineering
Bioengineering
Authors
Rainer Breitling, Eriko Takano,